3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other
1
Genitourinary
1
Conditions
Prostatic Neoplasms
63
Cardiovascular Diseases
3
Neoplasms
2
Stage II Prostate Adenocarcinoma
1
Sarcopenia
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatectomy
1
Prostate Cancer With ≤10 Bone Metastases
1
Prostate Cancer Metastatic Disease
1
Prostate Cancer Metastatic
1
Osteoporosis
1
Oligometastatic Prostate Carcinoma
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplasm Metastasis
1
Metastatic Neuroendocrine Prostate Cancer
1
Metastatic Castration-resistant Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer
1
Metabolic Syndrome
1
Metabolic Diseases
1
Eunuchism
1
Diabetes Mellitus
1
Dementia
1
Cognitive Dysfunction
1
Advanced Prostate Cancer
1
Interventions
Nutrition Assessment
2
tocilizumab
1
Tirzepatide
1
Testosterone
1
Standard of Care
1
Specimen Handling
1
Resistance Training
1
Practice Guidelines as Topic
1
Pioglitazone
1
Palliative Care
1
Metformin
1
Lysine Acetyltransferase 5
1
Immunoglobulin G
1
Gonadotropin-Releasing Hormone
1
Exercise
1
Disulfides
1
Diet, Carbohydrate-Restricted
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diabetes Mellitus
×
Gonadotropin-Releasing Hormone
×
Genitourinary
×
Clear all
NCT05773183
2023-03-17
MMetdMH
Royal College of Surgeons, Ireland
Unknown
60 enrolled